supplements may prove to be preferable to vitamin D 3 for patients with certain clinical conditions. However, there is limited evidence on the effects of 25(OH) D 3 -fortified foods on human vitamin D status and health, both in the general population and patients with certain conditions, and long-term randomised controlled trials are needed in this area.
Introduction
Vitamin D, a lipid-soluble vitamin that acts as a hormone (Nair & Maseeh 2012) , generally refers to ergocalciferol (vitamin D 2 ) and cholecalciferol (vitamin D 3 ) (Tripkovic et al. 2012) . Vitamin D 2 and vitamin D 3 are produced by fungi and the skin of vertebrates, respectively (Wacker & Holick 2013) . The role of vitamin D in musculoskeletal health is well established (Wolff et al. 2008) . Recently, vitamin D deficiency has been suggested to be associated with several non-musculoskeletal health outcomes, such as cardiovascular disease, certain cancers and type 2 diabetes, although mechanisms are not clear (Wang et al. 2017) . Vitamin D status is assessed by measuring the blood concentration of circulating (Hilger et al. 2014) , despite dispute about the thresholds for vitamin D deficiency and insufficiency (Spiro & Buttriss 2014) . In the UK, vitamin D deficiency is defined as 25(OH)D <25 nmol/l (SACN 2016) . The UK National Diet and Nutrition Survey (NDNS) reported that in 2008-2012, 24% of men and 21.7% of women (aged 19-64 years) had vitamin D deficiency (Bates et al. 2014) . With seasonal variation, the prevalence of hypovitaminosis D in the UK is higher during winter and spring. A cross-sectional study conducted in the UK by Hypponen and Power (2007) found that during the winter and spring months, 25(OH)D concentrations were <25 nmol/l, <40 nmol/l and <75 nmol/l in 15.5%, 46.6% and 87.1% of participants, respectively. There are several additional contributors to hypovitaminosis D, such as skin pigmentation, sunscreen usage and an increasingly indoor lifestyle, all of which reduce the cutaneous production of vitamin D (Holick 2004) .
D] (Holick 2009). Widespread hypovitaminosis D (vitamin D deficiency) is now acknowledged
Dietary intake of vitamin D is increasingly recognised as important for vitamin D status (O'Mahony et al. 2011) . Following a comprehensive review of the scientific literature, in 2016, the UK Scientific Advisory Committee on Nutrition (SACN) recommended a national population dietary intake of 10 lg vitamin D daily for everyone aged 4 years and older (SACN 2016) . As there are a limited number of foods that naturally contain vitamin D (Schmid & Walther 2013) , and uptake of supplements tends to be low (Datta & Vitolins 2016; Hennessy et al. 2017) , other strategies to improve vitamin D dietary intake are needed.
Vitamin D forms, metabolites and absorption
The two forms of vitamin D, D 2 and D 3 , have similar chemical structures apart from vitamin D 2 having an additional methyl group and double bond (Hollis 1984) . Humans and animals usually synthesise vitamin D 3 in the skin by converting 7-dehydrocholesterol in the epidermis to pre-vitamin D 3 in response to exposure to ultraviolet B radiation (UVB). Pre-vitamin D 3 then undergoes a temperature-dependent isomerisation to produce vitamin D 3 over approximately 3 days (Holick & Chen 2008) . Vitamin D 2 and vitamin D 3 , obtained from the diet, are absorbed with long-chain triglycerides in the small intestine and then incorporated into chylomicrons and transported via lymph to the circulation (Guo et al. 2018b (Ovesen et al. 2003) . Previous studies (Lu et al. 2007; Phillips et al. 2011; Guo et al. 2017b) have shown that the vitamin D concentrations of these foods can vary significantly between and within species (O'Mahony et al. 2011). For example, Phillips et al. (2011) collected and analysed the vitamin D 2 concentrations in 10 types of mushrooms from retail suppliers in the US and reported that they were low (0.1-0.3 lg/100 g) in Agaricus bisporus (white button, crimini, portabella) and enoki, moderate in shiitake and oyster (0.4-0.7 lg/100 g) and high in morel, chanterelle and maitake (5.2-28.1 lg/100 g). Furthermore, the vitamin D content of foods may relate to different production systems and the time of the year. For example, our study (Guo et al. 2017b) investigated eggs from three different production systems (organic, free range and indoor) over 5 months and showed a higher vitamin D 3 content in free-range eggs (57.2 AE 3.1 lg/kg) and organic eggs (57.2 AE 3.2 lg/kg) compared with indoor eggs (40.2 AE 3.1 lg/kg; P <0.001). A seasonal effect on the vitamin D content of eggs has also been reported by others (Mattila et al. 2011) . The study of Lu et al. (2007) Jetter et al. 2014; Catalano et al. 2015; Navarro-Valverde et al. 2016) , and concluded that the relative effectiveness of 25(OH)D 3 to vitamin D 3 ranged from 3.13 to 7.14. These variable results probably reflect differences in study designs and/or characteristics of the investigated subjects. In addition, our recent RCT (Guo et al. 2017a) 
Food fortification with vitamin D

Direct fortification
In the US and Canada, several common foods, such as milk, orange juices, breakfast cereals, yogurts and cheeses, are fortified with vitamin D (Holick et al. 2011) . In Europe, vitamin D mandatory and voluntary fortification policies and practice vary from country to country (Spiro & Buttriss 2014) . A meta-analysis was performed by Black et al. (2012) , which included 16 RCTs to evaluate the efficacy of vitamin D food fortification for improving vitamin D status. The results showed a mean vitamin D intake of 11 lg/day from fortified foods (range 3-25 lg/day) increased serum/ plasma 25(OH)D by 19.4 nmol/l (95% CI: 13.9-24.9), which corresponded to a 1.2 nmol/l (95% CI: 0.72, 1.68) increase in serum/plasma 25(OH)D for each 1 lg ingested. Thus, vitamin D direct fortification could be an effective strategy to increase vitamin D status in the general UK population.
In the US and Canada, much of the vitamin D intake is from fortified foods (Langlois et al. 2010; Fulgoni et al. 2011) . The major fortified foods contributing to vitamin D intake in these countries are fluid milk, ready-to-eat cereals and margarine (Calvo et al. 2004; Feldman et al. 2011) . The study by Langlois et al. (2010) (Calvo & Whiting 2013) questioned the adequacy of vitamin D-fortified foods in the US and Canada to meet the needs of all race, sex and age groups. Furthermore, a review by Kiely and Black (2012) pointed out well-designed, sustainable fortification strategies are needed to take account for diversity in food consumption patterns. In the UK, the food fortification policy was effective in preventing rickets in the 1950s; however, the mandatory vitamin D fortification policy ceased when overfortification of some milk products led to cases of hypercalcaemia in young children (British Pediatric Association 1956 ). More research is needed to explore the safety of vitamin D fortification, including the range of products and doses of vitamin D added in each.
Biofortification
Biofortification of vitamin D is an alternative strategy to increase vitamin D intakes in countries and regions where policies and practices limit use of direct fortification.
Our previous review provides an overview of recent vitamin D biofortification studies (Guo et al. 2018b) and found that the amount of vitamin D 3 and 25(OH)D 3 in eggs, fish and milk increases in response to vitamin D 3 supplementation of the diets of hens, fish and cows, respectively. However, research on 25(OH)D 3 supplementation of animals' diets is in its infancy, with data only available for hens (Guo et al. 2018b ). Interestingly, egg enrichment studies (Mattila et al. 2011; Duffy et al. 2017) (Mattila et al. 2011) .
Our recent milk biofortification study (Guo et al. 2018a ) used a total of 60 dairy cows randomised to vitamin D 3 or 25(OH)D 3 dietary supplementing treatments, within the maximum permitted European Union (EU) vitamin D 3 concentration (2 mg/day vitamin D 3 ) for feed. The results showed that supplementing dairy cows' feed with 25(OH)D 3 significantly increased the circulating plasma concentrations of 25(OH)D 3 in the cows. However, there was no significant effect of the treatment on milk 25(OH)D 3 concentrations (P = 0.193), with the mean 25(OH)D 3 milk concentrations for non-fortified and 25(OH)D 3 dietary treatments 869 and 1001 ng/kg, respectively. In addition, the vitamin D 3 concentration (100-3300 ng/kg) of the biofortified milk was negligible and far less than the current UK vitamin D recommended intake of 10 lg/day (SACN 2016). In the future, more studies are needed to explore which forms and doses of vitamin D added to animal diets, within the bounds of EU regulation (EFSA 2012; EC 2017), including those of fish, may have the greatest impact on human dietary quality.
Evidence from human intervention studies with 25(OH)D 3 -fortified foods
Evidence of the effect of 25(OH)D 3 -fortified foods on increasing vitamin D status in humans is limited. We were the first to compare the effects of dairy drinks fortified with either 20 lg 25(OH)D 3 or 20 lg vitamin D 3 on changes in human 24-hour vitamin D status (Guo et al. 2017a) . The results showed plasma 25(OH)D 3 was significantly higher after the 25(OH)D 3 -fortified dairy drink compared with the vitamin D 3 -fortified dairy drink and control (non-fortified dairy drink), which was reflected in the 1.5-fold and 1.8-fold greater incremental area under the curve of plasma 25(OH)D 3 for the 0-8 hour response, respectively. However, we did not investigate the long-term effects of consuming the 25(OH)D 3 -and vitamin D 3 -fortified dairy drinks.
Hayes et al. À6.4 AE 6.7 nmol/l) . In contrast to our study (Guo et al. 2017a) , there was no significant difference between vitamin D 3 and 25(OH)D 3 biofortified egg consumption in the participants' serum 25(OH)D concentrations. The reason is unknown, but may be because baseline vitamin D status (mean 46.2 nmol/l) was much higher than our study (mean 31.7 nmol/l), and vitamin D dose (3.5-4.5 lg/egg) for fortified eggs (Hayes et al. 2016) was only 20% of ours (20 lg/day) (Guo et al. 2017a) .
Currently A review by Brandi and Minisola (2013) concluded that for patient groups with specific conditions (such as chronic vitamin D osteomalacia, liver failure, latrogenic inhibition of liver 25-hydroxylases, inactivating mutations of genes encoding liver 25-hydroxylases, kidney failure with elevated parathyroid hormone, nephrosis, transplanted patients, male hypogonadism), supplementation with 25(OH)D 3 may prove to be preferable to vitamin D 3 . This might be because 25(OH)D 3 avoids the need for hepatic metabolism of vitamin D 3 to 25(OH)D 3, resulting in 25(OH)D 3 more quickly entering the blood circulation (Holick 1995; Ross et al. 2011 ).
Conclusions and future directions
Vitamin D deficiency and insufficiency have become global problems, especially where sunlight exposure is limited by latitude or cultural-or lifestyle-related factors (Hilger et al. 2014) . The UK government advisory committee, SACN, recommends a dietary intake of 10 lg/day of vitamin D for the UK general population (SACN 2016) . However, it is a great challenge to meet this recommendation solely from natural dietary sources and uptake of vitamin D supplements tends to be low. Two potential strategies to increase the vitamin D content of food are direct fortification and biofortification via animal diet supplementation. However, evidence from RCTs on the effect of vitamin D-fortified foods on human vitamin D status and health is still emerging. The limited available evidence suggests that the vitamin D metabolite, 25(OH)D 3, might be more efficient than vitamin D 2 and vitamin D 3 at raising plasma 25(OH)D 3 concentrations in general healthy subjects and that 25(OH)D 3 is the most appropriate form of vitamin D to use in certain clinical patients. Therefore, 25(OH)D 3 -fortified foods (including via direct fortification and biofortification) warrant further exploration, and additional RCTs should be conducted to investigate the effect of 25(OH)D 3 -fortified foods on vitamin D status and human health in both healthy subjects and clinical patients.
